The bivalent mRNA boosters from Pfizer-BioNTech and Moderna were 48% effective against symptomatic infection from the predominant omicron subvariant (XBB/XBB.1.5) in persons aged 18-49 years according to early data published by the CDC nbcnews.com Submitted by shiruken t3_10lcgah on January 25, 2023 at 10:58 PM in science 75 comments 337
[deleted] t1_j5wu3yu wrote on January 26, 2023 at 2:42 AM Reply to comment by [deleted] in The bivalent mRNA boosters from Pfizer-BioNTech and Moderna were 48% effective against symptomatic infection from the predominant omicron subvariant (XBB/XBB.1.5) in persons aged 18-49 years according to early data published by the CDC by shiruken [removed] Permalink Parent 12
Viewing a single comment thread. View all comments